ATLANTA, Oct. 23, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that it will release its third quarter of fiscal year 2014 financial results after the market close on Thursday, November 6, 2014. An investor conference call will follow on the same day at 4:30 p.m. ET.
The conference call will be hosted by Dan Myers, President and Chief Executive Officer, and Rick Eiswirth, Chief Operating Officer and Chief Financial Officer.
To participate in the call, please dial (877) 369-6586 (U.S. and Canada) or (253) 237-1165 (international). A live webcast will be available on the Investor Relations section of the corporate website at http://www.alimerasciences.com.
A replay of the conference call will be available beginning November 6, 2014 at 7:30 p.m. ET and ending on November 13, 2014 by dialing (855) 859-2056 (U.S. and Canada) or (404) 537-3406 (international), Conference ID Number: 25261645. A replay of the webcast will also be available on the corporate website.
About Alimera Sciences, Inc.
Alimera Sciences, Inc., based in Alpharetta, GA, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera Sciences Limited, a subsidiary of Alimera, is based in the United Kingdom and is the headquarters of Alimera’s European operations.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/alimera-sciences-to-release-third-quarter-2014-results-270199604.html
SOURCE Alimera Sciences, Inc.
Help employers find you! Check out all the jobs and post your resume.
